Abstract
There is limited data on the cardiovascular effects of norepinephrine (NE) in neonates. Our objective was to describe the clinical responses in neonates treated with NE infusion. This retrospective cohort study included neonates with evidence of shock and those who received NE infusion. Primary outcome: changes in mean blood pressure (MBP) at 6, 12, and 24 h post-initiation of NE. Secondary outcomes: Changes in (i) diastolic BP, systolic BP, and vasoactive inotrope score (VIS) at 6, 12, and 24 h, (ii) urine output after initiation of NE ii) pH, lactate, fraction of inspired oxygen (FiO2) after initiation of NE, and (iv) adverse outcomes. Fifty infants received NE with mean (SD) gestational age of 34.3 (4.3) weeks and a mean birth weight of 2215 (911) g. Treatment began at a median age of 36 (IQR: 15.2, 67.2) hours of life and lasted 30.5 (IQR: 12.7, 58) hours. MBP improved from 34.4 mm Hg (SD: 6.6) at baseline to 39.4 mm Hg (SD: 10.5, p < 0.001) at 6 h, to 39.6 mm Hg (SD: 12.1, p = 0.002) at 12 h and to 40.4 mm Hg (SD: 15.5, p = 0.004) at 24 h after NE initiation. Vasoactive inotrope score declined from 30 (20, 32) to 10 (4, 30; p < 0.001) at 24 h. Urine output improved within 24 h [1.5 ml/kg/h (0.5, 2.3) at baseline to 3 (1.9, 4.3) at 24 h; p = 0.04]. Oxygen requirement decreased after NE initiation.
Conclusion: The use of NE appears to be effective and safe for treating systemic hypotension in neonates. Trial registration: Being a retrospective study, trial registration was not considered.
What is known: |
• Dopamine has traditionally been used as the initial agent for treatment of neonatal hypotension. |
• Norepinephrine has recently been recommended as the first-choice vasopressor agent to correct hypotension in adults and pediatric patients, with insufficient data on the cardiovascular effects of NE in neonates |
What is new: |
• Mean blood pressure improved significantly at 6, 12, and 24 h with reduction in vasoactive infusion score at 12 and 24 h after norepinephrine infusion. |
• No significant change in heart rate or abnormal abdominal adverse effects noted in this study. |
Similar content being viewed by others
Data availability
Our manuscript has no associated data or the data will not be deposited.
Code availability
Not applicable.
Abbreviations
- BP:
-
Blood pressure
- BPD:
-
Broncho-pulmonary dysplasia
- BW:
-
Birth weight
- DBP:
-
Diastolic blood pressure
- FiO2:
-
Fraction of inspired oxygen
- IVH:
-
Intraventricular hemorrhage
- MBP:
-
Mean blood pressure
- NE:
-
Norepinephrine
- NEC:
-
Necrotizing enterocolitis
- NICU:
-
Neonatal intensive care unit
- PVL:
-
Periventricular leukomalacia
- ROP:
-
Retinopathy of prematurity
- SBP:
-
Systolic blood pressure
- SD:
-
Standard deviation
- VIS:
-
Vasoactive inotrope score
References
Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O (2008) Outcome and prognostic factors in neonates with septic shock. Pediatr Criti Care Med 9:186–191
Fanaroff JM, Wilson-Costello DE, Newman NS, Montpetite MM, Fanaroff AA (2006) Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics 117:1131–1135
Fanaroff AA, Fanaroff JM (2006) Short- and long-term consequences of hypotension in ELBW infants. Semin Perinatol 30:151–155
Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, et al (2012) Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 4:e7961
Moore GP, Lemyre B, Barrowman N, Daboval T (2013) Neurodevelopmental outcomes at 4 to 8 years of children born at 22 to 25 weeks’ gestational age: a meta-analysis. JAMA Pediatr 167:967–974
Goldstein RF, Thompson RJ, Oehler JM, Brazy JE (1995) Influence of acidosis, hypoxaemia, and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics 95:238–243
Martens SE, Rijken M, Stoelhorst GM, van Zwieten PHT, Zwinderman AH, Wit JM et al (2003) Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev 75:79–89
Al-Aweel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Richardson DK (2001) Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 21(5):272–278
Barrington KJ (2008) Hypotension and shock in the preterm infant. Semin Fetal Neonatal Med 13:16–23
Evans N (2006) Which inotrope for which baby? Arch Dis Child Fetal Neonatal Ed 9:F213–F220
Laughon M, Bose C, Allred E, O’Shea TM, Van Marter LJ, Bednarek F et al (2007) Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics 119:273–280
Noori S, Seri I (2012) Neonatal blood pressure support: The use of inotropes, lusitropes, and other vasopressor agents. Clin Perinatol 39:221–238
Meadows D, Edwards JD, Wilkins RG, Nightingale P (1988) Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16:663–666
Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103:1826–1831
Seri I (2001) Circulatory support of the sick preterm infant. Semin Neonatol 6(1):85–95
Tourneux P, Rakza T, Abazine A, Krim G, Strome L (2008) Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 97(2):177–180
Rizk MY, Lapointe A, Lefebvre F, Barrington KJ (2018) Norepinephrine infusion improves hemo- dynamics in the preterm infants during septic shock. Acta Paediatr 107(3):408–413
Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, Quero J et al (2005) Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 115:1501–1512
Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873
Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758–2765
Ceneviva G, Paschall JA, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:E19
Nuntnarumit P, Yang W, Bada-Ellzey HS (1999) Blood pressure measurements in the newborn. Clin Perinatol 26:981–996
Dilli D, Soylu H, Tekin N (2018) Neonatal hemodynamics and management of hypotension in newborns. Turk Pediatri Ars 53(Suppl 1):S65–S75
Barrington KJ, Stewart S, Lee S, et al (2002) Differing blood pressure thresholds in preterm infants, effects on frequency of diagnosis of hypotension and intraventricular haemorrhage. Pediatric Academic Societies Annual Meeting 2002, abstract. Baltimore, Maryland
Giesinger RE, McNamara PJ (2016) Hemodynamic instability in the critically ill neonate: an approach to cardiovascular support based on disease pathophysiology. Semin Perinatol 40(3):174–188
Hegyi T, Anwar M, Carbone MT et al (1996) Blood pressure ranges in premature infants: II. The first week of life Pediatrics 97(3):336–342
Batton B (2020) Neonatal blood pressure standards: what’s “normal”? Clin Perinatol 47(3):469–485
McIntosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF (2017) validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med 18(08):750–757
Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92(4):529–534
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al (1978) Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187(1):1–7
International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123(7):991–9
Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A (2003) Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 23(6):451–456
Liet JM, Boscher C, Gras-Leguen C, Gournay V, Debillon T, Roze JC (2002) Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus. J Pediatr 140:373–375
Jaillard S, Houfflin-Debarge V, Riou Y, Rakza T, Klosowski S, Lequien P et al (2001) Effects of catecholamines on the pulmonary circulation in the ovine fetus. Am J Physiol 281:R607–R614
Di Giantomasso D, Morimatsu H, May CN, Bellomo R (2003) Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med 31:2509–2513
Minneci PC, Deans KJ, Banks SM, Costello R, Csako G, Eichacker PQ et al (2004) Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock. Am J Physiol Heart Circ Physiol 287:H2545–H2554
Author information
Authors and Affiliations
Contributions
Shelly Gupta, Ankit Gupta, Sarvesh Thakur, and Gopal Agrawal: helped in study design, collected and analyzed the data, and drafted the manuscript. Gopal Agrawal and Sanjay Wazir: planned the study, supervised the collection and analysis of data, and did critical revision and finalization of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
Being a retrospective study, no ethical approval was sought.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Daniele De Luca
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gupta, S., Agrawal, G., Thakur, S. et al. The effect of norepinephrine on clinical and hemodynamic parameters in neonates with shock: a retrospective cohort study. Eur J Pediatr 181, 2379–2387 (2022). https://doi.org/10.1007/s00431-022-04437-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-022-04437-4